Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCSW) Notes Payables (2021 - 2025)

Historic Notes Payables for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to $500000.0.

  • HeartSciences' Notes Payables fell 7887.44% to $500000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $500000.0, marking a year-over-year decrease of 7887.44%. This contributed to the annual value of $2.6 million for FY2025, which is 41023.4% up from last year.
  • HeartSciences' Notes Payables amounted to $500000.0 in Q4 2025, which was down 7887.44% from $1.5 million recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Notes Payables registered a high of $2.6 million during Q2 2025, and its lowest value of $130000.0 during Q3 2022.
  • In the last 5 years, HeartSciences' Notes Payables had a median value of $1.1 million in 2022 and averaged $1.2 million.
  • Examining YoY changes over the last 5 years, HeartSciences' Notes Payables showed a top increase of 41023.4% in 2025 and a maximum decrease of 7887.44% in 2025.
  • HeartSciences' Notes Payables (Quarter) stood at $2.5 million in 2021, then plummeted by 54.8% to $1.1 million in 2022, then grew by 25.41% to $1.4 million in 2023, then surged by 67.01% to $2.4 million in 2024, then tumbled by 78.87% to $500000.0 in 2025.
  • Its Notes Payables stands at $500000.0 for Q4 2025, versus $1.5 million for Q3 2025 and $2.6 million for Q2 2025.